ABBV
Price
$185.43
Change
-$0.12 (-0.06%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
322.43B
30 days until earnings call
GILD
Price
$105.96
Change
-$1.24 (-1.16%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
90.79B
41 days until earnings call
Interact to see
Advertisement

ABBV vs GILD

Header iconABBV vs GILD Comparison
Open Charts ABBV vs GILDBanner chart's image
ABBVIE
Price$185.43
Change-$0.12 (-0.06%)
Volume$56.14K
Capitalization322.43B
Gilead Sciences
Price$105.96
Change-$1.24 (-1.16%)
Volume$92.03K
Capitalization90.79B
ABBV vs GILD Comparison Chart in %
Loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABBV vs. GILD commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a Buy and GILD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (ABBV: $185.55 vs. GILD: $107.20)
Brand notoriety: ABBV and GILD are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 64% vs. GILD: 81%
Market capitalization -- ABBV: $322.43B vs. GILD: $90.79B
ABBV [@Pharmaceuticals: Major] is valued at $322.43B. GILD’s [@Pharmaceuticals: Major] market capitalization is $90.79B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 2 FA rating(s) are green whileGILD’s FA Score has 1 green FA rating(s).

  • ABBV’s FA Score: 2 green, 3 red.
  • GILD’s FA Score: 1 green, 4 red.
According to our system of comparison, ABBV is a better buy in the long-term than GILD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 5 TA indicator(s) are bullish while GILD’s TA Score has 5 bullish TA indicator(s).

  • ABBV’s TA Score: 5 bullish, 3 bearish.
  • GILD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ABBV is a better buy in the short-term than GILD.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а +0.04% price change this week, while GILD (@Pharmaceuticals: Major) price change was -0.74% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.52%. For the same industry, the average monthly price growth was +4.77%, and the average quarterly price growth was +8.25%.

Reported Earning Dates

ABBV is expected to report earnings on Jul 25, 2025.

GILD is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.52% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABBV($322B) has a higher market cap than GILD($90.8B). ABBV has higher P/E ratio than GILD: ABBV (66.46) vs GILD (16.20). GILD YTD gains are higher at: 17.699 vs. ABBV (6.376). ABBV has higher annual earnings (EBITDA): 17.2B vs. GILD (10.5B). ABBV has more cash in the bank: 12.8B vs. GILD (7.26B). GILD has less debt than ABBV: GILD (25B) vs ABBV (59.4B). ABBV has higher revenues than GILD: ABBV (54.3B) vs GILD (27.1B).
ABBVGILDABBV / GILD
Capitalization322B90.8B355%
EBITDA17.2B10.5B164%
Gain YTD6.37617.69936%
P/E Ratio66.4616.20410%
Revenue54.3B27.1B200%
Total Cash12.8B7.26B176%
Total Debt59.4B25B238%
FUNDAMENTALS RATINGS
ABBV vs GILD: Fundamental Ratings
ABBV
GILD
OUTLOOK RATING
1..100
7611
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
1217
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5546
P/E GROWTH RATING
1..100
15100
SEASONALITY SCORE
1..100
3539

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABBV's Valuation (50) in the Pharmaceuticals Major industry is in the same range as GILD (50) in the Biotechnology industry. This means that ABBV’s stock grew similarly to GILD’s over the last 12 months.

ABBV's Profit vs Risk Rating (12) in the Pharmaceuticals Major industry is in the same range as GILD (17) in the Biotechnology industry. This means that ABBV’s stock grew similarly to GILD’s over the last 12 months.

ABBV's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as GILD (100) in the Biotechnology industry. This means that ABBV’s stock grew similarly to GILD’s over the last 12 months.

GILD's Price Growth Rating (46) in the Biotechnology industry is in the same range as ABBV (55) in the Pharmaceuticals Major industry. This means that GILD’s stock grew similarly to ABBV’s over the last 12 months.

ABBV's P/E Growth Rating (15) in the Pharmaceuticals Major industry is significantly better than the same rating for GILD (100) in the Biotechnology industry. This means that ABBV’s stock grew significantly faster than GILD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVGILD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
49%
MACD
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
35%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 14 days ago
56%
Bullish Trend 17 days ago
58%
Declines
ODDS (%)
Bearish Trend 9 days ago
46%
Bearish Trend 15 days ago
51%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
44%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KMDA7.950.69
+9.50%
Kamada Ltd
GDS28.961.42
+5.16%
GDS Holdings Limited
UONEK0.670.02
+3.28%
Urban One
AXON794.2511.01
+1.41%
Axon Enterprise
AESI13.56-0.18
-1.31%
Atlas Energy Solutions

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
+0.97%
PFE - ABBV
54%
Loosely correlated
+1.17%
AMGN - ABBV
49%
Loosely correlated
+1.85%
NVS - ABBV
45%
Loosely correlated
+1.11%
JNJ - ABBV
44%
Loosely correlated
+0.57%
GILD - ABBV
41%
Loosely correlated
+0.95%
More

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with AMGN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
+0.95%
AMGN - GILD
48%
Loosely correlated
+1.85%
BMY - GILD
45%
Loosely correlated
+0.23%
PFE - GILD
43%
Loosely correlated
+1.17%
ABBV - GILD
41%
Loosely correlated
+0.97%
JNJ - GILD
40%
Loosely correlated
+0.57%
More